Fingerprint
Dive into the research topics of 'Dual inhibition of PIK3C3 and FGFR as a new therapeutic approach to treat bladder cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dual inhibition of PIK3C3 and FGFR as a new therapeutic approach to treat bladder cancer
Chun Han Chen, Chun A. Changou, Tsung Han Hsieh, Yu Ching Lee, Cheng Ying Chu, Kai Cheng Hsu, Hao Ching Wang, Yu Chen Lin, Yan Ni Lo, Yun Ru Liu, Jing Ping Liou, Yun Yen
- Department of Pharmacology
- Joint Biobank
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- The Ph.D. Program for Translational Medicine
- Ph.D. Program in Drug Discovery and Development Industry
- Department of Pharmaceutical Sciences
- School of Pharmacy
- Graduate Institute of Clinical Medicine
- TMU Research Center of Cell Therapy and Regeneration Medicine
- TMU Research Center of Cancer Translational Medicine
- TMU Research Center of Drug Discivery
- International Ph.D. Program in Cell Therapy and Regenerative Medicine
- Graduate Institute of Biomedical Informatics
- TMU Research Center of Thoracic Medicine
- International Ph.D. Program for Translational Science
- Ph.D. Program in Medical Biotechnology
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine
- Master Program in Clinical Genomics and Proteomics
- CRISPR Gene Targeting Core Lab
- TMU Research Center for Digestive Medicine
Research output: Contribution to journal › Article › peer-review
38
Citations
(Scopus)